Search

Author/Creator Kalonji, Wilfried Mutombo

1. Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial. Issue 4 (April 2023)

Authors:
Betu Kumeso, Victor Kande; Kalonji, Wilfried Mutombo; Rembry, Sandra; Valverde Mordt, Olaf; Ngolo Tete, Digas; Prêtre, Adeline; Delhomme, Sophie; Ilunga Wa Kyhi, Médard; Camara, Mamadou; Catusse, Julie; Schneitter, Stefan; Nusbaumer, Morgane; Mwamba Miaka, Erick; Mahenzi Mbembo, Hélène; Makaya Ma...
Journal:
Lancet infectious diseases
Issue:
Volume 23:Issue 4(2023)
Page Start:
463
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial. Issue 10116 (13th January 2018)

Authors:
Mesu, Victor Kande Betu Ku; Kalonji, Wilfried Mutombo; Bardonneau, Clélia; Mordt, Olaf Valverde; Blesson, Séverine; Simon, François; Delhomme, Sophie; Bernhard, Sonja; Kuziena, Willy; Lubaki, Jean-Pierre Fina; Vuvu, Steven Lumeya; Ngima, Pathou Nganzobo; Mbembo, Hélène Mahenzi; Ilunga, Médard; Bo...
Journal:
Lancet
Issue:
Volume 391:Issue 10116(2017)
Page Start:
144
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search